{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:45:38Z","timestamp":1790109938560,"version":"4.0.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1038\/s41574-024-00978-w","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T14:05:33Z","timestamp":1710943533000},"page":"315-315","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Reply to \u2018Tumour fibrosis in dopamine agonist-exposed prolactinomas is a diminishing concern\u2019"],"prefix":"10.1038","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0618-6147","authenticated-orcid":false,"given":"Stephan","family":"Petersenn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9284-6289","authenticated-orcid":false,"given":"Maria","family":"Fleseriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2355-3447","authenticated-orcid":false,"given":"Shlomo","family":"Melmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,20]]},"reference":[{"key":"978_CR1","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","volume":"19","author":"S Petersenn","year":"2023","unstructured":"Petersenn, S. et al. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat. Rev. Endocrinol. 19, 722\u2013740 (2023).","journal-title":"Nat. Rev. Endocrinol."},{"key":"978_CR2","doi-asserted-by":"publisher","unstructured":"de Sousa, S. et al. Tumour fibrosis in dopamine agonist-exposed prolactinomas is a diminishing concern. Nat. Rev. Endocrinol. https:\/\/doi.org\/10.1038\/s41574-024-00976-y (2024).","DOI":"10.1038\/s41574-024-00976-y"},{"key":"978_CR3","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1530\/EJE-16-0087","volume":"175","author":"M Tampourlou","year":"2016","unstructured":"Tampourlou, M., Trifanescu, R., Paluzzi, A., Ahmed, S. K. & Karavitaki, N. therapy of endocrine disease: Surgery in microprolactinomas: effectiveness and risks based on contemporary literature. Eur. J. Endocrinol. 175, R89\u2013R96 (2016).","journal-title":"Eur. J. Endocrinol."},{"key":"978_CR4","doi-asserted-by":"publisher","first-page":"101290","DOI":"10.1016\/j.beem.2019.101290","volume":"33","author":"P Chanson","year":"2019","unstructured":"Chanson, P. & Maiter, D. The epidemiology, diagnosis and treatment of Prolactinomas: The old and the new. Best Pract. Res. Clin. Endocrinol. Metab. 33, 101290 (2019).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"978_CR5","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1210\/clinem\/dgz144","volume":"105","author":"AH Zamanipoor Najafabadi","year":"2020","unstructured":"Zamanipoor Najafabadi, A. H. et al. Surgery as a viable alternative first-line treatment for prolactinoma patients. A systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 105, e32\u2013e41 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"978_CR6","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s11102-023-01346-z","volume":"26","author":"VR van Trigt","year":"2023","unstructured":"van Trigt, V. R. et al. Care trajectories of surgically treated patients with a prolactinoma: why did they opt for surgery? Pituitary 26, 611\u2013621 (2023).","journal-title":"Pituitary"},{"key":"978_CR7","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/cen.13940","volume":"90","author":"R Steeds","year":"2019","unstructured":"Steeds, R. et al. Echocardiography and monitoring patients receiving dopamine agonist therapy for hyperprolactinaemia: A joint position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology. Clin. Endocrinol. 90, 662\u2013669 (2019).","journal-title":"Clin. Endocrinol."},{"key":"978_CR8","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1210\/clinem\/dgz076","volume":"105","author":"SMC De Sousa","year":"2020","unstructured":"De Sousa, S. M. C. et al. Impulse control disorders in dopamine agonist-treated hyperprolactinemia: prevalence and risk factors. J. Clin. Endocrinol. Metab. 105, e108\u2013e118 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"978_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1530\/EJE-18-0682","volume":"180","author":"AG Ioachimescu","year":"2019","unstructured":"Ioachimescu, A. G., Fleseriu, M., Hoffman, A. R., Vaughan Iii, T. B. & Katznelson, L. Psychological effects of dopamine agonist treatment in patients with hyperprolactinemia and prolactin-secreting adenomas. Eur. J. Endocrinol. 180, 31\u201340 (2019).","journal-title":"Eur. J. Endocrinol."},{"key":"978_CR10","doi-asserted-by":"crossref","unstructured":"Chen, Z. et al. Presurgical medical treatment in prolactinomas: surgical implications and pathological characteristics from 290 cases. J. Clin. Endocrinol. Metab. dgad758 (2024).","DOI":"10.1210\/clinem\/dgad758"}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-00978-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-00978-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-00978-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T15:28:30Z","timestamp":1713281310000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-00978-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,20]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["978"],"URL":"https:\/\/doi.org\/10.1038\/s41574-024-00978-w","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,20]]},"assertion":[{"value":"20 March 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}